Safety and Efficacy of MEM 3454 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease
NCT00454870
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
80
Enrollment
INDUSTRY
Sponsor class
Conditions
Alzheimer's Disease
Interventions
DRUG:
MEM 3454
Sponsor
Memory Pharmaceuticals